Sign in with Google
bearish
Pre-IPO Shouhui Tech (PHIP Updates) - Some Points Worth the Attention
500 Views21 May 2025 00:55
Investing in Shouhui is a risky bet on the industry's future due to disintermediation trend/tightening policy environment.Competition, decreasing commissions, weak fundamentals make the outlook bleak
What is covered in the Full Insight:
- Introduction
- Revenue Structure and Market Position
- Impact of Policies on Business
- Competition and Industry Trends
- Conclusion
Boomeranged on Fri, 30 May 2025 01:03
Shouhui attempts to stabilize stock price performance through reduce issuance scale (just 226 million circulating shares), but this does not solve the problem. The upper limit pricing of HK$8.08/share for HK IPO is too aggressive. As analyzed, poor fundamentals, gloomy outlook, tightening policy environment will eventually lead to a sharp drop in stock price. We suggest investors avoid this stock.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- [Japan M&A] Toyota Inds (6201) Proposed Takeover - It Looks Bad, and It's Worse Than It Looks
- US vs EU: Mutually Assured Destruction?
- Mayne Pharma (MYX AU): Twists and Turns as Cosette Chases a Get-Out-Of-Jail-Free Card
- TIP Customized Taiwan Select High Dividend Index Rebalance: 22 Changes as Expected
- Mayne Disagrees With Cosette On MAC
Top Unpaywalled Insights
More »- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
- [IO Technicals 2025/22] Bearish Momentum Strengthens
- Texas Power Play: Grid Sovereignty, Bitcoin, and the Future of AI
- Overview #27 – The Big Beautiful Tragi-Comedy Continues
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- China Healthcare Weekly (Jun.1)-Akeso/Summit's Disappointing Ph3 Readout,Valuation Outlook of Biokin02 Jun 2025
- China Healthcare Weekly (May 25) - Pfizer-3SBio's Record-Breaking Deal, RemeGen's HK$796Mn Placing25 May 2025
- Pre-IPO Shouhui Tech (PHIP Updates) - Some Points Worth the Attention21 May 2025
- Pre-IPO Jiangsu Hengrui Medicine H Share Listing (PHIP Updates) - Some Points Worth the Attention08 May 2025
- Pre-IPO Green Tea Group (PHIP Updates) - Some Points Worth the Attention30 Apr 2025
- Pre-IPO Shouhui Tech - The Business Outlook and Stock Price Performance Are Not Optimistic24 Jan 2024
x